Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 13, 2020

SELL
$8.89 - $24.94 $2.14 Million - $6.01 Million
-240,995 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$8.33 - $19.95 $980,174 - $2.35 Million
-117,668 Reduced 32.81%
240,995 $4.5 Million
Q3 2019

Nov 14, 2019

BUY
$6.86 - $10.46 $184,204 - $280,871
26,852 Added 8.09%
358,663 $3.75 Million
Q2 2019

Aug 13, 2019

BUY
$6.99 - $11.27 $492,235 - $793,633
70,420 Added 26.94%
331,811 $2.52 Million
Q1 2019

May 15, 2019

BUY
$5.05 - $11.62 $1.32 Million - $3.04 Million
261,391 New
261,391 $2.88 Million

Others Institutions Holding XBIT

About XBiotech Inc.


  • Ticker XBIT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,439,300
  • Market Cap $211M
  • Description
  • XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...
More about XBIT
Track This Portfolio

Track Sofinnova Investments, Inc. Portfolio

Follow Sofinnova Investments, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sofinnova Investments, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sofinnova Investments, Inc. with notifications on news.